An Efficacy and Safety Study of Omega-3-acid Ethyl Ester in Chinese Subjects With Hypertriglyceridemia.

Inclusion Criteria: * Baseline fasting serum TG level \> 200mg/dL and \<1000mg/dL, in subjects treated for HTG. * If on previous statin therapy, the treatment should have been kept stable in the last 3 months before entering the study. * Able and willing to give written informed consent. Exclusion Criteria: * Subjects taking fish oil capsules 8 weeks prior to inclusion in this study. * Known allergy to the active ingredient, or fish, soya, corn or olive oild (placebos). * Pregnant of lactating females. * Known increased risk of hemorrhage such as recent surgery, gastrointestinal hemorrhagic disease. * Significant hepatic disease. * Significantly reduced renal function. * Alcohol consumption \>30g for male and 20g for female daily. * Concomitant use of other investigational drugs. * Subject related to the investigator. * Subject expected to be not compliant.